In the erectile dysfunction condition, the pharmacological inhibition of PDE5 enhances relaxation of smooth muscle by NO, which activates cGMP, increasing its level in the corpum cavernosum, thus stimulating penile erection [13]. The gene discussed is PDE5A; the disease is erectile dysfunction.